![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spectrometry-portal-logo.jpg){kind=logo}
Advertisement
Organisation › Details
Xceleron (Group)
Founded in 1997 in York, UK, Xceleron provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. Xceleron pioneered the use of human microtracer and AMS and has unmatched robust processes and knowledge of experimental design. There are currently 6 drugs on the market that have used Xceleron AMS data in filing, and another 3 in late stages of development. In 2008, the company opened its US facility in Maryland. *
 |
Start | 2003-02-01 renamed |
 |
Industry | drug discovery services |
| Industry 2 | contract research (drugs) | |
| Street | Innovation Way, York Biocentre | |
| City | YO10 5NY Heslington, York | |
| Tel | +44-1904-561561 | |
| Fax | +44-1904-561560 | |
| Address record changed: 2008-12-07 | ||
| Basic data | Employees | n. a. |
| * Document for »About Section«: Xceleron. (6/13/11). "Press Release: Xceleron Announces Key Board and Executive Appointments. Increasing Demand from Big Pharma for Greater R&D Productivity". York. | ||
Record changed: 2011-11-27 |
More documents for Xceleron (Group)
To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com
» top
![Banner [iiito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
